The great Baraclude generic war with price or marketing power

Published: 2015-10-06 14:28:46

Updated: 2015-10-06 14:28:46

As the patent of ‘Baraclude(generic name: entecavir, BMS Pharmaceutical Korea), a chronic hepatitis B treatment, will be expired on 9^th of October, a great generic war will begin.

Baraclude is a product recording the highest sales among pharmaceutical products launched in the domestic market. It has become a peerless one in the domestic pharmaceutical market by recording KRW 154.9 billion in 2...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.